Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

Brain

Volumn 124, Issue 9, 2001, Pages 1821-1831

  Gherardi, R K ^a   Coquet, M ^b   Cherin, P ^c   Belec, L ^d   Moretto, P ^e   Dreyfus, P A ^a   Pellissier, J F ^f   Chariot, P ^a   Authier, F J ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HÔPITAL PELLEGRIN   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e CENTRE D ETUDES NUCLÉAIRES DE BORDEAUX GRADIGNAN   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Aluminium hydroxide; Drug adverse effect; Inflammatory myopathy; Macrophage; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; TETANUS TOXOID;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; FASCIITIS; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MACROPHAGIC MYOFASCIITIS; MAJOR CLINICAL STUDY; MALE; MICROANALYSIS; MUSCLE BIOPSY; MYALGIA; MYOPATHY; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ALUMINUM HYDROXIDE; ANIMALS; CHILD; ELECTRON PROBE MICROANALYSIS; FASCIITIS; FEMALE; HUMANS; INCLUSION BODIES; INJECTIONS, INTRAMUSCULAR; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; PREVALENCE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC; VIRAL HEPATITIS VACCINES;

EID: 0034841256     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.9.1821     Document Type: Article

References (51)

1. Experimental macrophagic myofasciitis: A long-term evaluation in different rat strains
2. Central nervous system disease in patients with macrophagic myofasciitis
3. Rôle des antigènes et des substances adjuvantes dans la réponse histologique au cours des granulomes experimentaux ('granulome immunogène')
4. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4 and IL-13-mediated signaling
5. Macrophagic myofasciitis: A new case of non-French origin
6. Aluminum-induced oxidative events and its relation to inflammation: A role for the metal in Alzheimer's disease
7. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis
8. Macrophagic myofasciitis: Improvement with antibiotic therapy
9. Gallium-67 scintigraphy in macrophagic myofasciitis
10. Polymyositis, dermatomyositis and inclusion-body myositis
11. In vivo absorption of aluminium-containing vaccine adjuvants using 26A1
12. Induction of autoimmunity through bystander effects - Lessons from immunological disorders induced by heavy metals
13. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts
14. Macrophagic myofasciitis: An emerging entity
15. Macrophagic myofasciitis: Evidence for chronic local and systemic immune activation associated with persistence of aluminum hydroxide-loaded macrophages in muscle
16. The antigenic value of toxoid precipitated by potassium alum
17. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid
18. Adjuvant properties of aluminum and calcium compounds
19. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts
20. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1
21. A study of the immunology of the chronic fatigue syndrome: Correlation of immunologic parameters to health dysfunction
22. Dermatomyositis and Whipple's disease
23. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein
24. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome
25. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome
26. Chronic fatigue syndrome: Clinical condition associated with immune activation
27. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons
28. Postimmunization (vaccination) injection-site reactions. A report of four cases and review of the literature
29. Whipple's disease without malabsorption: New atypical features
30. Nuclear microprobe
31. Muscle granulomas following intramuscular injection
32. The fasciitis-panniculitis syndromes. Clinical and pathologic features
33. Macrophagic myofasciitis. A report of a new Spanish case
34. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI
35. Sampling conditions for biological fluids for trace elements monitoring in hospital patients: A critical approach
36. Gulf War syndrome: Is it due to a systemic shift in cytokine balance towards a Th2 profile?
37. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia
38. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease
39. Immunological concepts of vaccine adjuvant activity
40. Aluminum compounds used as adjuvants in vaccines
41. Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate
42. Encephalitis after hepatitis B vaccination. Recurrent disseminated encephalitis or MS?
43. The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism
44. Macrophagic myofasciitis and aluminum-containing vaccines
45. Working group on the possible relationship between Hepatitis B vaccination and the chronic fatigue syndrome. Report
46. Immunological adjuvants
47. Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons
48. Prooxidant action of aluminum ion. Stimulation of iron-mediated lipid peroxidation by aluminum